Breaking News Instant updates and real-time market news.

2020-12-01 07:26:35 ADNT Adient $31.20 / -2.76 (-8.13%) 07:26 12/01/20 12/01 07:26 12/01/20 07:26	Adient price target raised to $36 from $29 at Credit Suisse Credit Suisse analyst Dan Levy raised the firm's price target on Adient to $36 from $29 and keeps an Outperform rating on the shares. While the bar was elevated into Adient's Q4 result, the analyst believes Adient cleared the bar on guidance, which is "arguably conservative." Free cash flow recovery remains on track, and Adient is paving a path to continued deleveraging, he contends. More importantly, Levy notes that the company demonstrated that its self-help initiative continues to push forward - not only can Adient fully recover past headwinds, but it can also achieve incremental efficiencies, reinforcing the opportunity for it to reach peer margin levels, and to return to near peak earnings levels despite the weaker end markets today versus 2017.	02 Dec
ADNT Adient $31.20 / -2.76 (-8.13%) 12/01/20 KeyBanc Adient price target raised to $36 from $31 at KeyBanc 12/01/20 RBC Capital Adient price target raised to $38 from $24 at RBC Capital 11/17/20 BofA Adient, Aptiv get double downgrades as BofA reshuffles auto industry ratings 11/17/20 BofA Adient downgraded to Underperform from Buy at BofA

2020-12-01 07:26:35

ADNT

Adient

$31.20 / -2.76 (-8.13%)

07:26

12/01/20

12/01

07:26

12/01/20

07:26

Adient price target raised to $36 from $29 at Credit Suisse

Credit Suisse analyst Dan Levy raised the firm's price target on Adient to $36 from $29 and keeps an Outperform rating on the shares. While the bar was elevated into Adient's Q4 result, the analyst believes Adient cleared the bar on guidance, which is "arguably conservative." Free cash flow recovery remains on track, and Adient is paving a path to continued deleveraging, he contends. More importantly, Levy notes that the company demonstrated that its self-help initiative continues to push forward - not only can Adient fully recover past headwinds, but it can also achieve incremental efficiencies, reinforcing the opportunity for it to reach peer margin levels, and to return to near peak earnings levels despite the weaker end markets today versus 2017.

02
Dec

ADNT Adient

$31.20 / -2.76 (-8.13%)

12/01/20 KeyBanc: Adient price target raised to $36 from $31 at KeyBanc

12/01/20 RBC Capital: Adient price target raised to $38 from $24 at RBC Capital

11/17/20 BofA: Adient, Aptiv get double downgrades as BofA reshuffles auto industry ratings

11/17/20 BofA: Adient downgraded to Underperform from Buy at BofA

TODAY'S FREE FLY STORIES

Recommendations	Sberbank price target raised to RUB 335 from RUB 325 at JPMorgan » 12:00 01/20/21 01/20 12:00 01/20/21 12:00 SBRCY Sberbank $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SBRCY Sberbank $0.00 / + (+0.00%) 05/22/20 JPMorgan Sberbank price target lowered to RUB 205 from RUB 215 at JPMorgan
Hot Stocks	dMY Technology II rises 13.2% » 12:00 01/20/21 01/20 12:00 01/20/21 12:00 DMYD dMY Technology II $18.95 / +2.16 (+12.86%) dMY Technology II is up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly DMYD dMY Technology II $18.95 / +2.16 (+12.86%) 10:00 Today dMY Technology II rises 15.7% 09:47 Today dMY Technology II rises 12.4% 12/09/20 dMY Technology II rises 15.9% 10/27/20 Genius Sports to become public company through dMY Technology II combination DMYD dMY Technology II $18.95 / +2.16 (+12.86%) 08:07 Today Craig-Hallum Genius Sports initiated with a Buy at Craig-Hallum DMYD dMY Technology II $18.95 / +2.16 (+12.86%) 10/27/20 Fly Intel: Pre-market Movers
Recommendations	Raiffeisen Bank price target raised to EUR 19 from EUR 16.70 at JPMorgan » 11:59 01/20/21 01/20 11:59 01/20/21 11:59 RAIFY Raiffeisen Bank $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RAIFY Raiffeisen Bank $0.00 / + (+0.00%) 11/24/20 Morgan Stanley Raiffeisen Bank downgraded to Underweight from Equal Weight at Morgan Stanley 11/17/20 UBS Raiffeisen Bank price target lowered to EUR 17 from EUR 18.60 at UBS 11/13/20 Morgan Stanley Raiffeisen price target raised to EUR 15.50 from EUR 15.30 at Morgan Stanley 10/28/20 Deutsche Bank Raiffeisen Bank price target lowered to EUR 17 from EUR 19 at Deutsche Bank
Recommendations	Garanti price target raised to TRY 16.40 from TRY 15.20 at JPMorgan » 11:58 01/20/21 01/20 11:58 01/20/21 11:58 TKGBY Garanti $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TKGBY Garanti $0.00 / + (+0.00%) 11/25/20 JPMorgan Garanti price target raised to TRY 15.20 from TRY 11.80 at JPMorgan 09/22/20 JPMorgan Garanti price target lowered to TRY 11.80 from TRY 12.10 at JPMorgan 07/16/20 JPMorgan Garanti price target raised to TRY 12.10 from TRY 11.70 at JPMorgan 05/22/20 JPMorgan Garanti price target raised to TRY 11.70 from TRY 10.60 at JPMorgan
Recommendations	Erste Group Bank price target raised to EUR 28 from EUR 25 at JPMorgan » 11:58 01/20/21 01/20 11:58 01/20/21 11:58 EBKDY Erste Group Bank $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EBKDY Erste Group Bank $0.00 / + (+0.00%) 01/11/21 UBS Erste Group Bank price target raised to EUR 29 from EUR 23 at UBS 10/29/20 UBS Erste Group Bank price target lowered to EUR 23 from EUR 24.80 at UBS 10/23/20 Societe Generale Erste Group Bank price target lowered to EUR 25 from EUR 26 at Societe Generale 10/21/20 Citi Erste Group Bank price target lowered to EUR 25 from EUR 25.85 at Citi

Recommendations	Akbank price target raised to TRY 11 from TRY 10.50 at JPMorgan » 11:57 01/20/21 01/20 11:57 01/20/21 11:57 AKBTY Akbank $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AKBTY Akbank $0.00 / + (+0.00%) 01/06/21 Citi Akbank upgraded to Buy from Neutral at Citi 11/25/20 JPMorgan Akbank price target raised to TRY 10.50 from TRY 8.40 at JPMorgan 09/22/20 JPMorgan Akbank price target lowered to TRY 8.40 from TRY 9.20 at JPMorgan 07/16/20 JPMorgan Akbank price target raised to TRY 9.20 from TRY 8.20 at JPMorgan
Periodicals	McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says » 11:55 01/20/21 01/20 11:55 01/20/21 11:55 MCK McKesson $182.77 / +0.29 (+0.16%) , MRNA Moderna $122.82 / -2.2 (-1.76%) McKesson (MCK) said in a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 12/20/20 Fly Intel: Top five weekend stock stories 12/20/20 FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S. 12/04/20 McKesson, Amgen sign strategic agreement to help improve cancer care 11/19/20 McKesson names Dr. Kevin Baggett as Chief Impact Officer MRNA Moderna $122.82 / -2.2 (-1.76%) 01/19/21 Moderna says cooperating with CDPH in probe of reports of adverse vaccine events 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/12/21 Moderna appoints Jose Vega as chief safety officer 01/12/21 Uber, Moderna to collaborate on 'uptake of COVID-19 vaccines' MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 12/24/20 Morgan Stanley Morgan Stanley sees greater FY22 COVID vaccine opportunity at McKesson 11/18/20 Jefferies Drug distributors' pullback on Amazon news an overreaction, says Jefferies 11/18/20 Goldman Sachs McKesson upgraded to Conviction Buy from Buy at Goldman Sachs 11/17/20 Goldman Sachs Goldman says Amazon news likely to pressure entire pharmacy supply chain MRNA Moderna $122.82 / -2.2 (-1.76%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/06/21 Piper Sandler Moderna price target raised to $170 after EU vaccine approval at Piper Sandler 01/04/21 Piper Sandler Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 11/03/20 McKesson raises FY21 adj. EPS view to $16.00-$16.50 from $14.70-$15.50 11/03/20 McKesson reports Q2 adj. EPS $4.80, consensus $3.87 11/02/20 Notable companies reporting before tomorrow's open 11/02/20 Notable companies reporting before tomorrow's open MRNA Moderna $122.82 / -2.2 (-1.76%) 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/05/20 Moderna reports Q2 EPS (31c), consensus (35c) 19 May 12 Feb MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 11/05/20 Distributors and J&J closing in on $26B opioid settlement deal, NY Times says 09/24/20 U.S. appeals court rejects novel opioid settlement framework, Reuters says 08/18/20 States seeking $26.4B from pharma companies in opioid litigation, WSJ reports 08/14/20 Trump says McKesson to help distribute vaccine under Warp Speed, Bloomberg says MRNA Moderna $122.82 / -2.2 (-1.76%) 01/14/21 Moderna plans to test COVID-19 Vaccine booster shot, CNBC says 01/13/21 Moderna CEO says COVID-19 will be around 'forever,' CNBC says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 01/05/21 Moderna, NIH studying if cutting doses can double vaccine supply, NYT says MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 11/17/20 Pharmacy owners, suppliers slide after Amazon launches new offerings 08/03/20 Fly Intel: Pre-market Movers MRNA Moderna $122.82 / -2.2 (-1.76%) 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 12/29/20 Fly Intel: Pre-market Movers 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 02/02/21 McKesson - MCK MCK MRNA MCK McKesson $182.77 / +0.29 (+0.16%) 11/03/20 Early notable gainers among liquid option names on November 3rd 08/03/20 Early notable gainers among liquid option names on August 3rd MRNA Moderna $122.82 / -2.2 (-1.76%) 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains 11/25/20 Moderna call volume above normal and directionally bullish 11/13/20 Unusually active option classes on open November 13th
Downgrade	PKO Bank Polski downgraded to Neutral from Overweight at JPMorgan » 11:52 01/20/21 01/20 11:52 01/20/21 11:52 PSZKY PKO Bank Polski $0.00 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PSZKY PKO Bank Polski $0.00 / + (+0.00%) 06/01/20 HSBC PKO Bank Polski downgraded to Hold from Buy at HSBC 06/01/20 Societe Generale PKO Bank Polski price target lowered to PLN 28 from PLN 30 at Societe Generale 06/01/20 JPMorgan PKO Bank Polski downgraded to Neutral from Overweight at JPMorgan
Hot Stocks	Schneider National takes investment stake in TuSimple » 11:52 01/20/21 01/20 11:52 01/20/21 11:52 SNDR Schneider National $23.31 / -0.03 (-0.13%) Schneider announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SNDR Schneider National $23.31 / -0.03 (-0.13%) 12/16/20 Schneider National to increase driver pay in 2021 10/29/20 Schneider National declares special dividend of $2.00 per share 07/20/20 Schneider National partners with Mastery Logistics to advance Quest ecosystem SNDR Schneider National $23.31 / -0.03 (-0.13%) 01/19/21 Credit Suisse Schneider National upgraded to Outperform from Neutral at Credit Suisse 12/14/20 Wells Fargo Schneider National downgraded to Underweight from Equal Weight at Wells Fargo 12/04/20 Evercore starts trucking coverage with preference for Old Dominion, Saia 12/04/20 Evercore ISI Schneider National initiated with an In Line at Evercore ISI SNDR Schneider National $23.31 / -0.03 (-0.13%) 10/29/20 Schneider National raises FY20 adj. EPS view to $1.18-$1.22 from $1.10-$1.25 10/29/20 Schneider National reports Q3 adj. EPS 31c, consensus 31c 07/30/20 Schneider National sees FY20 adj. EPS $1.10-$1.25, consensus $1.05 07/30/20 Schneider National reports Q2 adj. EPS 26c, consensus 19c 02/03/21 Schneider National - SNDR
Periodicals	EU seeks info from advertisers about Google's ad tech practices, Reuters says » 11:52 01/20/21 01/20 11:52 01/20/21 11:52 GOOG Alphabet $1,876.85 / +86.37 (+4.82%) , GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) European Union antitrust… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/12/21 Cowen Alphabet price target raised to $2200 from $1900 at Cowen 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/19/21 KeyBanc Alphabet price target to $2,060 from $1,970 at KeyBanc 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 06:05 Today Google probes actions of ethical AI leader Margaret Mitchell, Axios reports 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 06:05 Today Google probes actions of ethical AI leader Margaret Mitchell, Axios reports 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 12/22/20 FuboTV jumps as analysts up targets on 'strong upside momentum' 12/22/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Pre-market Movers GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 12/22/20 FuboTV jumps as analysts up targets on 'strong upside momentum' 12/22/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Pre-market Movers 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL GOOG Alphabet $1,876.85 / +86.37 (+4.82%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,872.00 / +88.85 (+4.98%) 09:55 Today Early notable gainers among liquid option names on January 20th 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish

Periodicals	State Street to eliminate 1,200 positions this year, BI reports » 11:47 01/20/21 01/20 11:47 01/20/21 11:47 STT State Street $77.70 / -0.82 (-1.04%) State Street Corp. is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street sees Q1 NII down about 68% sequentially 01/19/21 State Street sees Q1 fee revenue down y/y by low single digits 01/19/21 State Street board reinitiates share repurchase program of up to $475M in Q1 01/19/21 State Street faced 'a number of unprecedented challenges' in 2020 STT State Street $77.70 / -0.82 (-1.04%) 06:43 Today RBC Capital State Street price target raised to $86 from $78 at RBC Capital 01/11/21 Piper Sandler State Street price target raised to $81 from $69 at Piper Sandler 01/05/21 Wolfe Research State Street downgraded to Underperform from Peer Perform at Wolfe Research 01/05/21 Goldman Sachs State Street downgraded to Neutral from Buy at Goldman Sachs STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street reports Q4 EPS $1.39, consensus $1.56 10/16/20 State Street reports Q3 EPS $1.45, consensus $1.41 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open STT State Street $77.70 / -0.82 (-1.04%) 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says STT State Street $77.70 / -0.82 (-1.04%) 10/16/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum
Options	Spirit Airlines call volume above normal and directionally bullish » 11:45 01/20/21 01/20 11:45 01/20/21 11:45 SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit 'not ready' to make a call on what will happen with A319s near-term 10/29/20 Spirit Airlines sees potential to resume growth in mid-2021 10/29/20 Spirit Airlines plans to keep fleet of 31 A319s parked into 2021 10/29/20 Spirit Airlines sees FY21 CapEx about $100M-$125M SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Susquehanna Spirit Airlines price target raised to $22 from $19 at Susquehanna 01/08/21 BofA Spirit Airlines upgraded to Neutral from Underperform at BofA 12/23/20 Citi Airline demand in early 2021 'looks soft,' says Citi 12/16/20 Fly Intel: Top five analyst downgrades SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit Airlines sees total Q4 revenue down 43%-45% y/y, consensus $453.93M 10/28/20 Spirit Airlines reports Q3 EPS ($1.07), consensus ($2.72) 10/28/20 Notable companies reporting after market close 07/22/20 Spirit Airlines reports Q2 adj. EPS ($3.59), consensus ($2.66) 08 May SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/18/21 Biden to block Trump's plan to lift COVID travel restrictions, Reuters reports 01/18/21 Trump lifting COVID travel restrictions on Europe/Brazil, Reuters reports 01/15/21 U.K. tightens borders to prevent arrival of new COVID strains, Reuters says 01/12/21 U.S. to expand proof of no COVID rule to all international visitors, WSJ says SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/28/20 Fly Intel: After-Hours Movers SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Spirit Airlines call volume above normal and directionally bullish 11/16/20 Unusually active option classes on open November 16th 11/05/20 Spirit Airlines call volume above normal and directionally bullish 10/20/20 Spirit Airlines call volume above normal and directionally bullish
Recommendations	LafargeHolcim price target raised to CHF 57 from CHF 48 at UBS » 11:39 01/20/21 01/20 11:39 01/20/21 11:39 HCMLY LafargeHolcim $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/14/21 Berenberg LafargeHolcim initiated with a Hold at Berenberg 01/08/21 JPMorgan LafargeHolcim price target raised to CHF 59 from CHF 51 at JPMorgan 12/07/20 Jefferies LafargeHolcim initiated with a Hold at Jefferies 11/18/20 Deutsche Bank LafargeHolcim initiated with a Buy at Deutsche Bank HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	HeidelbergCement price target raised to EUR 71.50 from EUR 68.50 at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 HDELY HeidelbergCement $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HDELY HeidelbergCement $0.00 / + (+0.00%) 01/14/21 Berenberg HeidelbergCement initiated with a Buy at Berenberg 01/08/21 JPMorgan HeidelbergCement price target raised to EUR 70 from EUR 60 at JPMorgan 01/06/21 Societe Generale HeidelbergCement upgraded to Buy from Hold at Societe Generale 12/16/20 Credit Suisse HeidelbergCement price target raised to EUR 69 from EUR 60 at Credit Suisse
Recommendations	GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09:56 Today Fly Intel: Top five analyst downgrades 06:32 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 05:29 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/15/21 Deutsche Bank GlaxoSmithKline initiated with a Hold at Deutsche Bank GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/08/20 Moderna slides as analyst says sell on rising COVID vaccine competition 03/03/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st

Hot Stocks	First Eagle Alternative Credit COO, CFO Terry Olson to retire » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) First Eagle Alternative… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan
Recommendations	Ferguson price target raised to 10,050 GBp from 9,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 FERGY Ferguson $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FERGY Ferguson $0.00 / + (+0.00%) 01/14/21 Berenberg Ferguson downgraded to Sell from Hold at Berenberg 01/05/21 UBS Ferguson U.K. sale not that material, says UBS 01/05/21 RBC Capital Ferguson forecasts adjusted at RBC Capital 12/09/20 Barclays Ferguson price target raised to 9,000 GBp from 8,000 GBp at Barclays
Recommendations	CRH price target raised to 3,600 GBp from 3,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 CRH CRH $44.88 / -0.12 (-0.27%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRH CRH $44.88 / -0.12 (-0.27%) 09/21/20 Ash Grove to upgrade import terminal in Florida CRH CRH $44.88 / -0.12 (-0.27%) 01/14/21 Berenberg CRH initiated with a Hold at Berenberg 01/08/21 JPMorgan CRH price target raised to EUR 41 from EUR 40 at JPMorgan 01/06/21 Societe Generale CRH upgraded to Buy on apparent Democratic majority at Societe Generale 01/06/21 Societe Generale CRH upgraded to Buy from Hold at Societe Generale CRH CRH $44.88 / -0.12 (-0.27%) 12/23/20 HeidelbergCement working to sell California operations, Bloomberg reports
Recommendations	Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BKIMF Bankinter $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays 10/23/20 UBS Bankinter price target lowered to EUR 3.45 from EUR 3.55 at UBS
Recommendations	Bankia price target raised to EUR 1.52 from EUR 1.09 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BNKXF Bankia $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals BNKXF Bankia $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares BNKXF Bankia $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankia price target raised to EUR 1.20 from EUR 1.10 at JPMorgan 11/25/20 HSBC Bankia downgraded to Hold from Buy at HSBC 10/29/20 UBS Bankia price target lowered to EUR 1.09 from EUR 1.15 at UBS 10/20/20 UBS Bankia price target lowered to EUR 1.15 from EUR 1.30 at UBS BNKXF Bankia $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports 09/03/20 Bankia, Caixabank say they are considering merger, Bloomberg says

Periodicals	Tesla lowers Model 3 prices in Europe, Electrek reports » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 TSLA Tesla $844.31 / -0.26 (-0.03%) Tesla has reduced Model 3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 EU passenger car registrations down 3.3% in December 01/14/21 Tesla director sells 10K shares of common stock 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Tesla Model Y achieves 5-Star overall safety rating from NHTSA TSLA Tesla $844.31 / -0.26 (-0.03%) 09:16 Today JPMorgan JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous 07:39 Today Deutsche Bank Tesla price target raised to $890 from $705 at Deutsche Bank 06:48 Today Oppenheimer Tesla price target raised to $1,036 from $486 at Oppenheimer 01/19/21 Jefferies Tesla price target raised to $775 from $650 at Jefferies TSLA Tesla $844.31 / -0.26 (-0.03%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close 14 Feb TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/19/21 Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports 01/18/21 Tesla says Model Y deliveries in China have officially begun 01/13/21 NHTSA asks Tesla to recall 158,000 cars over faulty touchscreens, Reuters says TSLA Tesla $844.31 / -0.26 (-0.03%) 01/14/21 Fly Intel: Pre-market Movers 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla 01/08/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers 01/27/21 Tesla - TSLA TSLA Tesla $844.31 / -0.26 (-0.03%) 08:55 Today Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th 01/11/21 Notable open interest changes for January 11th
Recommendations	Banco de Sabadell price target raised to EUR 0.40 from EUR 0.27 at UBS » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 BNDSF Banco de Sabadell $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals BNDSF Banco de Sabadell $0.00 / + (+0.00%) 11/27/20 Keefe Bruyette Sabadell downgraded to Underperform from Market Perform at Keefe Bruyette 11/05/20 UBS Banco de Sabadell price target lowered to EUR 0.27 from EUR 0.28 at UBS 11/03/20 Deutsche Bank Banco de Sabadell price target raised to EUR 0.45 at Deutsche Bank 10/20/20 UBS Banco de Sabadell price target lowered to EUR 0.28 from EUR 0.30 at UBS BNDSF Banco de Sabadell $0.00 / + (+0.00%) 09/08/20 Sabadell exploring strategic options, Bloomberg reports
Recommendations	Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse » 11:33 01/20/21 01/20 11:33 01/20/21 11:33 BAYRY Bayer $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Bayer says FDA approves addition of OS and other data to Nubeqa prescribing info 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine 12/22/20 Bayer, Veracyte announce new collaboration to advance precision oncology BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 67 at Morgan Stanley 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/07/20 Stifel Atara Biotherapeutics price target raised to $33 from $28 at Stifel 12/07/20 Roth Capital Bayer collaboration a testament to Atara's T-cell prowess, says Roth Capital BAYRY Bayer $0.00 / + (+0.00%) 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09/30/20 Bayer confirms 2020 adjusted view, sees 2021 core EPS 'slightly' down from 2020 09/30/20 Bayer expects 2021 sales at approximately 2020 levels BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 00:00 Today PDUFA Date for Vericiguat
Recommendations	Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 GRFS Grifols $19.38 / -0.4 (-2.02%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GRFS Grifols $19.38 / -0.4 (-2.02%) 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M 10/09/20 Grifols begins anti-SARS-CoV-2 hyperimmune globulin trial GRFS Grifols $19.38 / -0.4 (-2.02%) 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley 12/09/20 Morgan Stanley Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley 11/06/20 Morgan Stanley Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley 10/30/20 Berenberg Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg GRFS Grifols $19.38 / -0.4 (-2.02%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports GRFS Grifols $19.38 / -0.4 (-2.02%) 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers
Recommendations	Orion Oyj price target raised to EUR 35 from EUR 30 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 ORINF Orion Oyj $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
Tomorrow at 00:00

2021 Conservation Finance Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Oncology Investor Virtual Conference Conferences

Virtual Conference
CLAR ...
Tomorrow at 00:00

Virtual Outdoor Day Conferences

Virtual Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Adient price target raised to $36 from $29 at Credit Suisse

TODAY'S FREE FLY STORIES

Get Full Fly Access